1
2
3
4
5
6
7
8
9
10
11
12
13 | On 4/6/23 starting at 11:50 AM, Licensing Program Analyst (LPA) L. Francisco arrived unannounced to conuct complaint investigation for the above allegations. LPA met with Executive Director, Dolly Rizvi and explained the purpose of the visit.
During the course of the investigation, LPA obtained information, collected documents, reviewed records and interviewed staff. It was alleged facility did not provide adequate care resulting in resident sustaining unexplained pressure sores while in care. Based on information obtained, R1 sustained pressure sores on lower extremities. W1 stated when R1 was admitted to the new facility, an open sore was observed in R1's private area. However, based on record review, LPA observed a fax on 6/27/22 to R1's primary care physician of facility requesting a doctor's order of ATB ointment and calmesoptine to be applied to R1's thigh and groin area.
REPORT CONTINUES ON 9099C |